U.K. sequencing study surfaces new findings about tumor DNA

The study found certain tumors were more likely to carry mutations that could inform patient care.

January 12, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | U.K. sequencing study surfaces new findings about tumor DNA The study indicated that for the tumors with a high percentage of these mutations whole tumor sequencing was justified in patient care. By Andrew Joseph STAT+ | JPM 2024: FogPharma's new CEO, Mathai Mammen, unveils 'contrarian' plan in oncology CEO Mathai Mammen plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers. By Allison DeAngelis HHS's Xavier Becerra, once an 'invisible' secretary, is racing to cement a clearer legacy Health secretary Xavier Becerra, once 'invisible,' is finally making inroads with the White House. Is it enough to change his legacy? By Sarah Owermohle

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser